{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:47:40Z","timestamp":1790196460278,"version":"4.1.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Substantial progress has been made in understanding the involvement of malondialdehyde-acetaldehyde (MAA) adducts in rheumatoid arthritis (RA) pathogenesis. This systematic review synthesizes current evidence on the role of MAA-modified macromolecules and anti-MAA antibodies in the development, manifestation, and progression of RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEDLINE, EMBASE, the Cochrane Library, Scopus, and SciFinder were searched through May 6, 2025. Studies were screened based on predefined inclusion\/exclusion criteria. Study characteristics were extracted, and quality assessments were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MAA-modified proteins and MAA-specific autoreactive B cells are elevated in synovial and lung tissues of RA patients. Anti-MAA antibodies are enriched in RA-derived synovial fluids compared to serum. Serum levels of anti-MAA IgG and IgA are increased prior to RA onset, and though not RA-specific, were higher in RA patients than those with other conditions. Anti-MAA antibodies do not cross-react with other autoantibodies, such as anti-citrullinated protein autoantibodies, and can be detected in sera from seronegative RA patients. Elevated anti-MAA antibody levels correlate with progression of joint, lung, and cardiovascular complications, as well as biologic treatment responses. Human and animal studies have begun to elucidate mechanisms by which MAA and anti-MAA antibody might contribute to inflammatory and fibrotic changes in RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This review provides a comprehensive overview of MAA and its involvement in RA pathogenesis. MAA adducts contribute to loss of immune tolerance and promote both inflammation and fibrosis in RA. Given associations of anti-MAA antibodies with RA disease activity and complications, MAA-related pathways hold promise as both biomarkers and treatment targets in RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , identifier CRD4202454490.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1648290","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:29:41Z","timestamp":1763965781000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Malondialdehyde-acetaldehyde modified macromolecules and resulting autoantibodies in rheumatoid arthritis pathogenesis: a Systematic Literature Review"],"prefix":"10.3389","volume":"16","author":[{"given":"Wenxian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozima","family":"Aripova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant R.","family":"England","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tate M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Duryee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey M.","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted R.","family":"Mikuls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis \u2014 Common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"New Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: Extra-articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S528487","article-title":"The role and mechanism of protein post\u2212Translational modification in rheumatoid arthritis","volume":"18","author":"Wen","year":"2025","journal-title":"J Inflammation Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001228","article-title":"Current view on the pathogenic role\u00a0of\u00a0anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"7","author":"Catrina","year":"2021","journal-title":"RMD Open"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/antiox11061153","article-title":"The role of reactive oxygen\u00a0species in the rheumatoid arthritis-associated synovial microenvironment","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants."},{"key":"B6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12291-014-0446-0","article-title":"Free radicals: properties, sources, targets, and their implication in various diseases","volume":"30","author":"Phaniendra","year":"2015","journal-title":"Indian J Clin biochemistry: IJCB."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117963","article-title":"Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease","volume":"95","author":"Holvoet","year":"1995","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/tx00031a001","article-title":"Mechanisms and biological relevance of lipid peroxidation initiation","volume":"6","author":"Dix","year":"1993","journal-title":"Chem Res Toxicology."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9150(98)00153-1","article-title":"Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury","volume":"141","author":"Hill","year":"1998","journal-title":"Atherosclerosis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2017.06.004","article-title":"Autoreactivity to malondialdehyde-modifications in rheumatoid arthritis is linked to disease activity and synovial pathogenesis","volume":"84","author":"Gr\u00f6nwall","year":"2017","journal-title":"J autoimmunity."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/BF02534718","article-title":"Studies on peroxidized lipids. V. Formation and characterization of 1,4-dihydropyridine-3,5-dicarbaldehydes as model of fluorescent components in lipofuscin","volume":"19","author":"Kikugawa","year":"1984","journal-title":"Lipids."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230431","article-title":"Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration","volume":"23","author":"Tuma","year":"1996","journal-title":"Hepatol (Baltimore Md.)."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1021\/tx970069t","article-title":"Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay","volume":"10","author":"Xu","year":"1997","journal-title":"Chem Res Toxicology."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/00000374-200105051-00035","article-title":"The chemistry and biological effects of malondialdehyde-acetaldehyde adducts","volume":"25","author":"Thiele","year":"2001","journal-title":"Alcoholism Clin Exp Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107440","article-title":"Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease","volume":"9","author":"Anderson","year":"2014","journal-title":"PloS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.08.001","article-title":"Malondialdehyde\/acetaldehyde adduct (MAA) is the dominant epitope following MDA modification of proteins in atherosclerosis","volume":"49","author":"Duryee","year":"2010","journal-title":"Free Radical Biol Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"12948","DOI":"10.3390\/ijms222312948","article-title":"Malondialdehyde-acetaldehyde modified (MAA) proteins differentially effect the inflammatory response in macrophage, endothelial cells and animal models of cardiovascular disease","volume":"22","author":"Duryee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"109400","DOI":"10.1016\/j.intimp.2022.109400","article-title":"A novel reactive aldehyde species inhibitor prevents the deleterious effects of ethanol in an animal model of alcoholic liver disease","volume":"113","author":"Duryee","year":"2022","journal-title":"Int Immunopharmacology."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5373","article-title":"Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease","volume":"31","author":"Rolla","year":"2000","journal-title":"Hepatol (Baltimore Md.)."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000469","article-title":"Identification of immunoglobulin G autoantibody against malondialdehyde-acetaldehyde adducts as a novel serological biomarker for ulcerative colitis","volume":"13","author":"Duryee","year":"2022","journal-title":"Clin Trans Gastroenterology."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/art.38969","article-title":"Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis","volume":"67","author":"Thiele","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken N.J.)."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex212","article-title":"Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint","volume":"56","author":"Mikuls","year":"2017","journal-title":"Rheumatol (Oxford England)."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/art.40900","article-title":"Malondialdehyde-acetaldehyde adducts and antibody responses in rheumatoid arthritis-associated interstitial lung disease","volume":"71","author":"England","year":"2019","journal-title":"Arthritis Rheumatol (Hoboken N.J.)."},{"key":"B24","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Res ed.)."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4571(199704)48:4<349::AID-ASI8>3.0.CO;2-W","article-title":"Chemical Abstracts Service Chemical Registry System: History, scope, and impacts","volume":"48","author":"Weisgerber","year":"1997","journal-title":"J Am Soc Inf Science."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.5195\/jmla.2018.283","article-title":"A systematic approach to searching: an efficient and complete method to develop literature searches","volume":"106","author":"Bramer","year":"2018","journal-title":"J Med Library Association: JMLA."},{"key":"B27","article-title":"The\u00a0Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses","author":"Wells","year":""},{"key":"B28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res methodology."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.prosdent.2022.05.019","article-title":"Development and\u00a0validation of a risk-of-bias tool for assessing in vitro studies conducted in dentistry: The QUIN","volume":"131","author":"Sheth","year":"2024","journal-title":"J prosthetic dentistry."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.01.022","article-title":"Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions","volume":"56","author":"Mikuls","year":"2018","journal-title":"Int immunopharmacology."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/art.41424","article-title":"Autoantibodies to malondialdehyde-acetaldehyde are detected prior to rheumatoid arthritis diagnosis and after other disease specific autoantibodies","volume":"72","author":"Mikuls","year":"2020","journal-title":"Arthritis Rheumatol (Hoboken N.J.)."},{"key":"B32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/07853890.2020.1724321","article-title":"Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients","volume":"52","author":"Kononoff","year":"2020","journal-title":"Ann Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.627986","article-title":"A comprehensive evaluation of the relationship between different igG and igA anti-modified protein autoantibodies in rheumatoid arthritis","volume":"12","author":"Gr\u00f6nwall","year":"2021","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"107260","DOI":"10.1016\/j.intimp.2020.107260","article-title":"Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis","volume":"91","author":"Petro","year":"2021","journal-title":"Int immunopharmacology."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2020.1795244","article-title":"Antibodies to malondialdehyde-acetaldehyde modified low-density lipoprotein in patients with newly diagnosed inflammatory joint disease","volume":"50","author":"Kononoff","year":"2021","journal-title":"Scandinavian J Rheumatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"10547","DOI":"10.1038\/s41598-022-14954-9","article-title":"Serum anti-malondialdehyde-acetaldehyde IgA antibody concentration improves prediction of coronary atherosclerosis beyond traditional risk factors in patients with rheumatoid arthritis","volume":"12","author":"Lomzenski","year":"2022","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13075-023-03009-7","article-title":"Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations","volume":"25","author":"de Moel","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13075-023-03180-x","article-title":"Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression","volume":"25","author":"Rodriguez-Martinez","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1136\/rmdopen-2023-003480","article-title":"Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association","volume":"9","author":"van den Beukel","year":"2023","journal-title":"RMD Open"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/JPER.23-0604","article-title":"Associations between periodontitis and serum anti-malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis: A case-control study","volume":"95","author":"Lee","year":"2024","journal-title":"J Periodontology."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/art.42916","article-title":"Antibodies to malondialdehyde-acetaldehyde adduct are associated with prevalent and incident rheumatoid arthritis-associated interstitial lung disease in U.S. Veterans","volume":"76","author":"Aripova","year":"2024","journal-title":"Arthritis Rheumatol (Hoboken N.J.)."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3745","article-title":"Combined collagen-induced arthritis and organic dust-induced airway inflammation to model inflammatory lung disease in rheumatoid arthritis","volume":"34","author":"Poole","year":"2019","journal-title":"J Bone Mineral Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"108069","DOI":"10.1016\/j.intimp.2021.108069","article-title":"The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung disease","volume":"100","author":"Mikuls","year":"2021","journal-title":"Int immunopharmacology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12931-022-02085-8","article-title":"Increased susceptibility to organic dust exposure-induced inflammatory lung disease with enhanced rheumatoid arthritis-associated autoantigen expression in HLA-DR4 transgenic mice","volume":"23","author":"Poole","year":"2022","journal-title":"Respir Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1203548","article-title":"Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis","volume":"14","author":"Aripova","year":"2023","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"105320","DOI":"10.1016\/j.jbc.2023.105320","article-title":"Autoreactive B cells against malondialdehyde-induced protein cross-links are present in the joint, lung, and bone marrow of rheumatoid arthritis patients","volume":"299","author":"Sahlstr\u00f6m","year":"2023","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00221.2023","article-title":"Combined repetitive inhalant endotoxin and collagen-induced arthritis drive inflammatory lung disease and arthritis severity in a testosterone-dependent manner","volume":"326","author":"Poole","year":"2024","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00153.2024","article-title":"Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes profibrotic responses in human lung fibroblasts","volume":"328","author":"Aripova","year":"2024","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"110303","DOI":"10.1016\/j.clim.2024.110303","article-title":"Macrophage activation and inflammatory priming by anti-MAA antibodies in rheumatoid arthritis","volume":"265","author":"Afonso","year":"2024","journal-title":"Clin Immunol (Orlando Fla.)."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1557583","article-title":"Lung disease in relation to unique monocyte-macrophage subpopulations induced by combined inhalant endotoxin and collagen-induced arthritis","volume":"16","author":"Poole","year":"2025","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/art.43149","article-title":"Peripheral biomarker signatures in rheumatoid arthritis-associated interstitial lung disease","volume":"77","author":"Wheeler","year":"2025","journal-title":"Arthritis Rheumatol (Hoboken N.J.)."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1565133","article-title":"Restoring immune tolerance in pre-RA: immunometabolic dialogue between gut microbiota and regulatory T cells","volume":"16","author":"Gao","year":"2025","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/art.42549","article-title":"Rheumatoid arthritis-specific autoimmunity in the lung before and at the onset of disease","volume":"75","author":"Joshua","year":"2023","journal-title":"Arthritis Rheumatol (Hoboken N.J.)."},{"key":"B54","doi-asserted-by":"publisher","first-page":"109010","DOI":"10.1016\/j.intimp.2022.109010","article-title":"Peptidyl arginine deiminase expression and macrophage polarization following stimulation with citrullinated and malondialdehyde-acetaldehyde modified fibrinogen","volume":"110","author":"Aripova","year":"2022","journal-title":"Int immunopharmacology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"106433","DOI":"10.1016\/j.intimp.2020.106433","article-title":"Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts","volume":"83","author":"Thiele","year":"2020","journal-title":"Int Immunopharmacology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","article-title":"Increased cardiovascular risk in rheumatoid arthritis: Mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"BMJ (Online)."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74238","article-title":"Rheumatoid arthritis and heart failure: A narrative review","volume":"16","author":"Deepika","year":"2024","journal-title":"Cureus."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2017.07.018","article-title":"Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging","volume":"13","author":"Zimmerman","year":"2017","journal-title":"Redox Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.04.023","article-title":"Clinically\u00a0relevant\u00a0activity of the novel RASP inhibitor reproxalap in allergic conjunctivitis: the phase 3 ALLEVIATE trial","volume":"230","author":"Clark","year":"2021","journal-title":"Am J Ophthalmology."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S441009","article-title":"The phase 3 INVIGORATE trial of reproxalap in patients with seasonal allergic conjunctivitis","volume":"17","author":"Starr","year":"2023","journal-title":"Clin Ophthalmol (Auckland N.Z.)."},{"key":"B61","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/biom12030393","article-title":"Aldehyde trapping by ADX-102 is protective against cigarette smoke and alcohol mediated lung cell injury","volume":"12","author":"Ochoa","year":"2022","journal-title":"Biomolecules."},{"key":"B62","doi-asserted-by":"publisher","first-page":"102903","DOI":"10.1016\/j.jaut.2022.102903","article-title":"Autoantibodies targeting malondialdehyde-modifications in rheumatoid arthritis regulate osteoclasts via inducing glycolysis and lipid biosynthesis","volume":"133","author":"Sakuraba","year":"2022","journal-title":"J Autoimmunity."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1648290\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:29:41Z","timestamp":1763965781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1648290\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2025.1648290"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1648290","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"article-number":"1648290"}}